| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c87938e600391373c35c0f44f69fa01f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d3b134bb1581b3c38dc851d6910c5d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d193dcdb29b9c15fd3b521cd7fa34f8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_287642ca3f6a739a7f01dd1b62744960 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 |
| filingDate |
2005-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f56680eb047ea71ed2a91adb3b9d4c60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb51a583a7ed22b8c9465b9301804243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d763a6a54d9c74bcbd528d64628e8a4 |
| publicationDate |
2006-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006062681-A1 |
| titleOfInvention |
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| abstract |
A novel formulation is provided that serves to inhibit the inflammatory response in animals. The formulation comprises, as a first component an effective amount of a curcuminoid species and an effective amount of a second component selected from the group consisting of an alpha-acid species or a beta-acid species or derivatives thereof. The composition provides synergistic anti-inflammatory effects in response to physical or chemical injury or abnormal immune stimulation due to a biological agent or unknown etiology. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2604262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1993528-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420132-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8192768-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8557306-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8541383-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1993528-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008106013-A |
| priorityDate |
2004-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |